Materias dentro de su búsqueda.
Mostrando 661 - 680 Resultados de 13,801 Para Buscar 'MTVA~', tiempo de consulta: 1.51s Limitar resultados
  1. 661
    por Camacho Vidal, Sergio
    Publicado 2001
    Tesis Libro
    Proceso para la puesta en servicio de un transformador de potencia de 5/6.25 MVA /
  2. 662
    por Lizama Cámara, Yahir Abraham
    Publicado 2010
    Tesis Libro
    "Diseño de un sistema de lavado en vivo para aisladores de un transformador de 300 MVA"
  3. 663
    Publicado 2002
    “…This document concerns the award of a contract for the supply of thirty-five 18 kV cast-resin rectifier power transformers rated 464 kVA to 2 MVA and 26 protective enclosures. Following a market survey (MS-2920/SL/LHC) carried out among 56 firms in sixteen Member States, a call for tenders (IT-3007/SL/LHC) was sent on 12 August 2002 to eight firms in five Member States. …”
    Enlace del recurso
    Proposal for the Award of a Contract for the Supply of 18kV Power Transformers Rated 464 kVA to 2 MVA
  4. 664
    “…MRTX1719 selectively inhibited PRMT5 in the presence of MTA, which is elevated in MTAP del cancers, and inhibited PRMT5-dependent activity and cell viability with >70-fold selecti­vity in HCT116 MTAP del compared with HCT116 MTAP wild-type (WT) cells. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    MRTX1719 Is an MTA-Cooperative PRMT5 Inhibitor That Exhibits Synthetic Lethality in Preclinical Models and Patients with MTAP-Deleted Cancer
  5. 665
    “…Ultrasound-guided manual vacuum aspiration (USG-MVA) is an ideal outpatient surgical treatment alternative to traditional surgical evacuation. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Ultrasound-guided manual vacuum aspiration (USG-MVA) with cervical preparation for early pregnancy loss: A cost-effectiveness analysis
  6. 666
    “…However, when these results were compared with data from a previous clinical trial, where BCG was boosted with MVA85A (BCG-MVA85A), MVA85A induced significantly higher levels (>2-fold) of antigen 85-specific CD4+ T cells (both antigen and peptide pool responses) than boosting with BCG, up to 52 weeks post-vaccination (p = 0.009). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
    Safety and Immunogenicity of Boosting BCG Vaccinated Subjects with BCG: Comparison with Boosting with a New TB Vaccine, MVA85A
  7. 667
    “…Pairs of ponies were vaccinated with MVAVP2, MVAVP7 or MVANS3 and both MVA vector and AHSV antigen-specific antibody responses were analysed. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
    Induction of Antibody Responses to African Horse Sickness Virus (AHSV) in Ponies after Vaccination with Recombinant Modified Vaccinia Ankara (MVA)
  8. 668
    Enlace del recurso
    Enlace del recurso
    Texto
    P19-19. MVA vaccines are efficiently cross-presented by DCs and do not enhance HIV replication in DC/T cell cultures
  9. 669
    “…BACKGROUND: Fumonisin B(1 )is a cancerogenic mycotoxin produced by Fusarium verticillioides and other fungi. Sphingopyxis sp. MTA144 can degrade fumonisin B(1), and a key enzyme in the catabolic pathway is an aminotransferase which removes the C2-amino group from hydrolyzed fumonisin B(1). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
    Enhancement of solubility in Escherichia coli and purification of an aminotransferase from Sphingopyxis sp. MTA144 for deamination of hydrolyzed fumonisin B(1)
  10. 670
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
    Management of recently traumatized maxillary central incisors by partial pulpotomy using MTA: Case reports with two-year follow-up
  11. 671
    “…We prepared a Modified Vaccinia virus Ankara (MVA) vector encoding nucleoprotein and matrix protein 1 (MVA−NP+M1) and conducted a phase I clinical trial in healthy adults. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
    Potent CD8(+) T-Cell Immunogenicity in Humans of a Novel Heterosubtypic Influenza A Vaccine, MVA−NP+M1
  12. 672
    “…PURPOSE: A non-randomised, open-label, Phase I safety and immunogenicity dose-finding study to assess the safety and immunogenicity of the candidate TB vaccine Modified Vaccinia virus Ankara expressing Antigen 85A (MVA85A) from Mycobacterium tuberculosis (MTB) in healthy adult volunteers previously vaccinated with BCG. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Effect of vaccine dose on the safety and immunogenicity of a candidate TB vaccine, MVA85A, in BCG vaccinated UK adults
  13. 673
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Immune responses triggered by HIV/AIDS vaccine candidates, derived from MVA-B, with deletions in several immune regulatory genes
  14. 674
    “…In this study, we evaluate the quality of influenza specific T cell responses in a clinical trial using MVA-NP+M1 vaccination followed by influenza virus challenge. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Examination of Influenza Specific T Cell Responses after Influenza Virus Challenge in Individuals Vaccinated with MVA-NP+M1 Vaccine
  15. 675
    “…BACKGROUND: The metastasis-associated gene 1 (MTA1) has been identified as one critical regulator of tumor metastasis. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    MTA1 promotes the invasion and migration of non-small cell lung cancer cells by downregulating miR-125b
  16. 676
    “…Therefrom we can compute the ratio “Medial Temporal Atrophy index” at both sides as follows: MTAi = (A − B)× 10/C. Conclusions: The MTAi is a simple 2D-method for measuring the relative extent of atrophy in the MTL in relation to the global brain atrophy. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    MTA index: a simple 2D-method for assessing atrophy of the medial temporal lobe using clinically available neuroimaging
  17. 677
    “…METHOD: Secondary analyses of data from the MTA included multivariate analyses, and intent-to-treat random-effects regression models were used. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Treatment of Children With Attention-Deficit/Hyperactivity Disorder (ADHD) and Irritability: Results From the Multimodal Treatment Study of Children With ADHD (MTA)
  18. 678
    “…The aim of the present study was to assess the histopathologic response of dental pulp to pulp capping using MTA or CEM cement in diabetic rats. Thirty two Wistar male rats aged between 8 and 10 weeks (weight: 200-250g) were divided into two groups of diabetic (n=16) and healthy (n=16) animals and then subdivided into MTA and CEM subgroups. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Histopathologic Responses of the Dental Pulp to Calcium-Enriched Mixture (CEM) and Mineral Trioxide Aggregate (MTA) in Diabetic and Non-Diabetic Rats
  19. 679
    “…METHODS: By specific siRNA transfection and MTT assay, we evaluated the effects of metastasis-associated gene 1 (MTA1) in osteoblast growth. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Hypoxia-induced MTA1 promotes MC3T3 osteoblast growth but suppresses MC3T3 osteoblast differentiation
  20. 680
    “…PURPOSE: To evaluate the predictive and prognostic value of pretreatment metabolic tumor volume (MTV) in patients with treated by radiotherapy (RT) or concurrent chemoradiotherapy (CCRT). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Predictive and Prognostic Value of Metabolic Tumor Volume (MTV) in Patients with Laryngeal Carcinoma Treated by Radiotherapy (RT) / Concurrent Chemoradiotherapy (CCRT)
Herramientas de búsqueda: RSS